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CDCIHRSA ADVISORY COMMITTEE ON HIV, VIRAL HEPATITIS AND STD 

PREVENTION AND TREATMENT 

Authol"ity 
The CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and 
Treatment was established under Section 222 of the Public Health Service (PHS) Act [42 U.S.C. 
§2 l7aJ , as amended. The committee is governed by the provisions of the Federal Advisory 
Committee Act, as amended, (5 U.S .C. App.), which sets forth standards for the formation and 
use of advisory committees. 
Objective and Scope of Activities 
The Secretary, Department of Health and Human Services (HHS), and by delegation, the 
Director, Centers for Disease Control and Prevention (CDC), and the Administrator, Health 
Resources and Services Administration (HRSA), are authorized by the PHS Act to: (I) conduct, 
encourage, cooperate with, and assi st other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, investigations, experiments, 
demonstrations, and studies relating to the causes, diagnosis, treatment, control, and prevention 
of physical and mental diseases, and other impairments; (2) assist states and their political 
subdivisions in preventing, suppressing, and treating communicable diseases and other 
preventable conditions and in promoting health and well -being; and (3) assist public and non­
profit private entities in preventing, controlling and treating sexually transmitted di seases 
(STDs), including HIV (human immunodeficiency virus); (4) improve health and achieve health 
equity through access to quality services and a skilled health workforce and innovative 
programs; and, (5) support healthcare services to persons living with or at risk for HlV, Viral 
Hepatitis and other sexually transmitted diseases (STDs), and the education of health 
professionals and the public about HIV, Viral Hepatitis and other STDs. 
Description of Duties 
The CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and 
Treatment shall advise the Secretary, HHS; the Director, CDC; and the Administrator, HRSA, 
regarding objectives, strategies, policies, and priorities for HIV, Viral Hepatitis, and other STDs; 
prevention and treatment efforts including surveillance of HIV infection, AIDS, Viral Hepatitis, 
other STDs, and related behaviors; epidemiologic, behavioral , health services, and laboratory 
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research on HIV IAIDS, Viral Hepatitis, and other STDs; identification of policy issues related to 
HIVNiral Hepatitis/STD professional education, patient healthcare delivery, and prevention 
services; agency policies about prevention of HIVIAIDS, Viral Hepatitis and other STDs; 
treatment, healthcare delivery, and research and training; strategic issues influencing the ability 
of CDC and HRSA to fulfill their missions ofproviding prevention and treatment services; 
programmatic efforts to prevent and treat HIV, Viral Hepatitis, and other STDs; and, support to 
the agencies in their development of responses to emerging health needs related to HIV, Viral 
Hepatitis and other STDs. 
To assist CDC and HRSA in carrying out their responsibilities, the CDCIHRSA Advisory 
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT) will 
assess CDC's and HRSA's activities related to the HIV, Acquired Immunodeficiency Syndrome 
(AIDS), Viral Hepatitis and other STDs, and make recommendations for the future directions of 
CDC's and HRSA's programs to prevent, control, and treat STDs, HIV/AIDS, and Viral 
Hepatitis. 
CHACHSPT will advise CDC and HRSA on activities related to the prevention and control of 
HIVIAIDS, Viral Hepatitis and other STDs, the support ofhealthcare services to persons living 
with HIV IAIDS, and the education of health professionals and the public about HIV IAIDS, Viral 
Hepatitis and other STDs. The committee will support the agencies' process of identifying and 
responding to the prevention and health service delivery needs of affected communities, and the 
needs of individuals living with or at risk for HIV, Viral Hepatitis and other STDs. 
Agency or Official to Whom the Committee Reports 
The committee reports to the Secretary, HHS; the Director, CDC; and the Administrator, HRSA. 
Support 
Management and support services shall be provided by CDC and HRSA. 
Estimated Annual Operating Costs and Staff Years 
Estimated annual cost for operating the committee, including compensation and travel expenses 
for members, but excluding staff support is $54,310. Estimate of annual person-years of staff 
support required is 0.93, at an estimated annual cost of$146,105. 
Designated Federal Officer 
CDC and HRSA will each select a fulltime or permanent part-time Federal employee to serve as 
the Designated Federal Officers (DFO) to attend each committee meeting and ensure that all 
procedures are within applicable statutory, regulatory, and HHS General Administration Manual 
directives. The DFOs will approve and prepare all meeting policies and agendas, call all of the 
committee and subcommittee meetings, adjourn any meeting when the DFOs deems adjournment 
to be in the public interest, and chair meetings when directed to do so by the official to whom the 
committee reports. The DFOs or their designee(s) shall be present at all meetings of the full 
committee and subcommittees. 
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Meetings 
Meetings shall be held approximately twice a year at the call of the DFOs, in consultation with 
the co-chairs. The D FOs shall also approve the agenda and shall be present at all meetings. 
Meetings shall be open to the public except as determined otherwise by the Secretary, HHS, or 
other official to whom the authority has been delegated; in accordance with the Government in 
the Sunshine Act (5 U.S.C. §552b(c)) and Section 10(d) of the Federal Advisory Committee Act; 




Unless renewed by appropriate action prior to its expiration, the CHACHSPT will terminate two 
years from the date this charter is filed. 
Membership and Designation 
The committee shall consist of 18 public members, including 2 Co-chairs. CDC and HRSA each 
shall recommend nominees for half of the committee membership. Members shall be selected by 
the Secretary, or hislher designee, from authorities knowledgeable in the fields ofpublic health; 
epidemiology; laboratory practice; immunology; infectious diseases; drug abuse; behavioral 
science; health education; healthcare delivery; state health programs; clinical care; preventive 
health; medical education; health services and clinical research; and healthcare financing. The 
committee shall also include representation ofpersons with HIV infection; minority populations; 
state and local health and education agencies; AIDSIHIV Niral Hepatitis/STD community-based 
organizations; and the ethical or religious community. At least four members shall be persons 
living with HIV / AIDS. Members shall be deemed Special Government Employees. 
There shall also be nonvoting ex officio members from the following agencies: the National 
Institutes of Health; the Centers for Medicare and Medicaid Services; the Substance Abuse and 
Mental Health Services Administration; the Agency for Healthcare Research and Quality; the 
Indian Health Service; the Food and Drug Administration; the HHS Office of HIV / AIDS and 
Infectious Disease Policy; and such additional officers of the U.S. government as the Secretary 
deems necessary for the committee to effectively carry out its functions. 
There shall also be nonvoting liaison representative from the Presidential Advisory Council on 
HIV / AIDS; and such other nonvoting representatives from organizations with interests in the 
prevention and control of HIV / AIDS, STD and Viral Hepatitis, as the Secretary deems necessary 
for the committee to effectively carry out its functions. Liaisons are deemed representatives. 
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Members shall be invited to serve for overlapping terms of up to four years, except that any 
member appointed to fill a vacancy for an unexpired term shall be appointed for the remainder of 
that term. Terms of more than two years are contingent upon the renewal of the committee by 
appropriate action prior to its termination. A member may serve 180 days after the expiration of 
that member's term if a successor has not taken office. 
Subcommittees 
Subcommittees composed of members and nonmembers of the parent committee may be 
established with the approval of the Secretary, HHS, or hislher designee. The subcommittees 
must report back to the parent committee and do not provide advice or work products directly to 
the agency. The Department Committee Management Officer will be notified upon 
establishment of each subcommittee and will be provided information on its name, membership, 
function, and estimated frequency of meetings. 
Recordkeeping 
The records of the board, established subcommittees, or other subgroups of the board, shall be 
managed in accordance with General Records Schedule 26, Item 2, or other approved agency 
records disposition schedule. These records shall be available for public inspection and copying, 
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